This report discusses the clinical use of intravenous inotropic therapy for acute heart failure decompensation and the challenges of weaning these infusions in late-stage disease.
No takes yet. Share an insight, caveat, or question.
Supports limiting prolonged inotrope exposure in advanced HF; leaves open prospective trials of weaning strategies.
Lynne W. Stevenson (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: